[Immune Tolerance Mediated by TIM-3,LAG-3 and BTLA and Their Reversion in Hematological Malignancies-Review]. [electronic resource]
- Zhongguo shi yan xue ye xue za zhi Oct 2016
- 1594-1597 p. digital
Publication Type: Journal Article; Review
1009-2137
10.7534/j.issn.1009-2137.2016.05.056 doi
Antigens, CD Hematologic Neoplasms Hepatitis A Virus Cellular Receptor 2 Humans Immune Tolerance Immunotherapy Receptors, Immunologic T-Lymphocytes Lymphocyte Activation Gene 3 Protein